
M-Delta
Productby Amgen
Heard in 2 episodes across 2 shows since Oct 2026
M-Delta is an Amgen development program or product designation.
Episodes
2
across 2 shows
First heard
Oct 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
2
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 2 |
| Nov 2026 | 0 |
Email alert
Email me when M-Delta comes up on a podcast
One email a week at most, with the new episodes that mention M-Delta. Free, no account needed, unsubscribe in one click.
What experts have said about M-Delta
1 statement · 1 positive
Amgen’s M-Delta results are highly impressive after moving into earlier-line treatment.
“the results that we're seeing as this by specific in particular has been moved to an earlier line of treatment are incredibly impressive”
Open the episode · Ep. 394 - Security concerns in U.S., China reshaping biotechListen at 32:09
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring M-Delta, newest first